352 related articles for article (PubMed ID: 19349929)
1. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
Edelbroek PM; van der Heijden J; Stolk LM
Ther Drug Monit; 2009 Jun; 31(3):327-36. PubMed ID: 19349929
[TBL] [Abstract][Full Text] [Related]
2. Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation.
Cheung CY; van der Heijden J; Hoogtanders K; Christiaans M; Liu YL; Chan YH; Choi KS; van de Plas A; Shek CC; Chau KF; Li CS; van Hooff J; Stolk L
Transpl Int; 2008 Feb; 21(2):140-5. PubMed ID: 17944802
[TBL] [Abstract][Full Text] [Related]
3. Dried blood spot measurement of tacrolimus is promising for patient monitoring.
Hoogtanders K; van der Heijden J; Christiaans M; van de Plas A; van Hooff J; Stolk L
Transplantation; 2007 Jan; 83(2):237-8. PubMed ID: 17264824
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry.
van der Heijden J; de Beer Y; Hoogtanders K; Christiaans M; de Jong GJ; Neef C; Stolk L
J Pharm Biomed Anal; 2009 Nov; 50(4):664-70. PubMed ID: 19155152
[TBL] [Abstract][Full Text] [Related]
5. Application of automated serial blood sampling and dried blood spot technique with liquid chromatography-tandem mass spectrometry for pharmacokinetic studies in mice.
Wong P; Pham R; Whitely C; Soto M; Salyers K; James C; Bruenner BA
J Pharm Biomed Anal; 2011 Nov; 56(3):604-8. PubMed ID: 21784595
[TBL] [Abstract][Full Text] [Related]
6. Adapting dried blood spot sampling for an anti-therapeutic antibody immunogenicity assay.
Xiang Y; Welch M; Amaravadi L; Stebbins C
J Immunol Methods; 2013 Jul; 393(1-2):53-60. PubMed ID: 23603618
[TBL] [Abstract][Full Text] [Related]
7. Dried blood spot sampling in combination with LC-MS/MS for quantitative analysis of small molecules.
Li W; Tse FL
Biomed Chromatogr; 2010 Jan; 24(1):49-65. PubMed ID: 20017122
[TBL] [Abstract][Full Text] [Related]
8. Dried blood spots in toxicology: from the cradle to the grave?
Stove CP; Ingels AS; De Kesel PM; Lambert WE
Crit Rev Toxicol; 2012 Mar; 42(3):230-43. PubMed ID: 22348353
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic drug monitoring of tacrolimus with the dried blood spot method.
Hoogtanders K; van der Heijden J; Christiaans M; Edelbroek P; van Hooff JP; Stolk LM
J Pharm Biomed Anal; 2007 Jul; 44(3):658-64. PubMed ID: 17184953
[TBL] [Abstract][Full Text] [Related]
10. Facilitating pharmacokinetic studies in children: a new use of dried blood spots.
Patel P; Mulla H; Tanna S; Pandya H
Arch Dis Child; 2010 Jun; 95(6):484-7. PubMed ID: 20501544
[TBL] [Abstract][Full Text] [Related]
11. Clinical validation of dried blood spot sampling in therapeutic drug monitoring of ciclosporin A in allogeneic stem cell transplant recipients: direct comparison between capillary and venous sampling.
Wilhelm AJ; Klijn A; den Burger JC; Visser OJ; Veldkamp AI; Janssen JJ; Swart EL
Ther Drug Monit; 2013 Feb; 35(1):92-5. PubMed ID: 23296096
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring by dried blood spot: progress to date and future directions.
Wilhelm AJ; den Burger JC; Swart EL
Clin Pharmacokinet; 2014 Nov; 53(11):961-73. PubMed ID: 25204403
[TBL] [Abstract][Full Text] [Related]
13. Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact.
Youhnovski N; Bergeron A; Furtado M; Garofolo F
Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2951-8. PubMed ID: 21913274
[TBL] [Abstract][Full Text] [Related]
14. Volumetric absorptive microsampling and dried blood spot microsampling vs. conventional venous sampling for tacrolimus trough concentration monitoring.
Veenhof H; Koster RA; Junier LAT; Berger SP; Bakker SJL; Touw DJ
Clin Chem Lab Med; 2020 Sep; 58(10):1687-1695. PubMed ID: 32412437
[TBL] [Abstract][Full Text] [Related]
15. Determination of mycophenolic acid and its phenyl glucuronide in human plasma, ultrafiltrate, blood, DBS and dried plasma spots.
Heinig K; Bucheli F; Hartenbach R; Gajate-Perez A
Bioanalysis; 2010 Aug; 2(8):1423-35. PubMed ID: 21083343
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of cyclosporine levels in transplant recipients using self-administered fingerprick sampling.
Yonan N; Martyszczuk R; Machaal A; Baynes A; Keevil BG
Clin Transplant; 2006; 20(2):221-5. PubMed ID: 16640530
[TBL] [Abstract][Full Text] [Related]
17. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations.
Spooner N; Ramakrishnan Y; Barfield M; Dewit O; Miller S
Bioanalysis; 2010 Aug; 2(8):1515-22. PubMed ID: 21083351
[TBL] [Abstract][Full Text] [Related]
18. Dried blood spots analysis with mass spectrometry: Potentials and pitfalls in therapeutic drug monitoring.
Antunes MV; Charão MF; Linden R
Clin Biochem; 2016 Sep; 49(13-14):1035-46. PubMed ID: 27179588
[TBL] [Abstract][Full Text] [Related]
19. Implementing DBS methodology for the determination of Compound A in monkey blood: GLP method validation and investigation of the impact of blood spreading on performance.
Fan L; Lee J; Hall J; Tolentino EJ; Wu H; El-Shourbagy T
Bioanalysis; 2011 Jun; 3(11):1241-52. PubMed ID: 21649500
[TBL] [Abstract][Full Text] [Related]
20. Dried blood spot testing: a novel approach for the therapeutic drug monitoring of ziprasidone-treated patients.
Mercolini L; Mandrioli R; Protti M; Conca A; Albers LJ; Raggi MA
Bioanalysis; 2014 Jun; 6(11):1487-95. PubMed ID: 25046049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
